ReviewInternational urology and nephrology2026
Psoriasis and chronic kidney disease: insights into mechanisms and novel therapeutic outlooks.
Review in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pathological association between psoriasis and chronic kidney disease (CKD) has important clinical and mechanistic implications. The two diseases interact through multidimensional mechanisms, yet the underlying regulatory networks and clinical translational potential remain incompletely understood. This review synthesizes epidemiological and mechanistic evidence on the psoriasis-CKD relationship. It focuses on immune pathways-including IL-23/IL-17 axis, T helper 17/regulatory T cell imbalance, and shared immune-related hub genes, such as MX1, DDX58, and ISG20-as well as purine dysmetabolism, oxidative stress, treatment-related nephrotoxicity, and the proposed "dialysis-skin axis." We systematically dissected the association network centered on immune-metabolic crosstalk and explored the underlying mechanisms related to oxidative stress, comorbidity associations, and special populations. The available evidence provides a theoretical framework for developing integrated prevention and treatment strategies targeting psoriasis-related immune-metabolic pathways and offers clinical considerations for patients with advanced kidney disease, those undergoing dialysis, and transplant recipients.
Indexed as
Identifiers
42536250What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.